ホーム>>Signaling Pathways>> Chromatin/Epigenetics>> Histone Demethylases>>GSK-LSD1 2HCl

GSK-LSD1 2HCl

カタログ番号GC15368

不可逆的で選択的なLSD1阻害剤

Products are for research use only. Not for human use. We do not sell to patients.

GSK-LSD1 2HCl 化学構造

Cas No.: 1431368-48-7

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$46.00
在庫あり
5mg
$46.00
在庫あり
25mg
$157.00
在庫あり
100mg
$396.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

GSK-LSD1 2HCl is a selective inhibitor of LSD1 with IC50 value of 16 nM [1].

Lysine (K) -specific demethylase 1A (LSD1) is a flavin-dependent histone demethylase that demethylates mono- and di-methylated lysines and plays an important role in oocyte growth, embryogenesis and tissue-specific differentiation. LSD1 plays a role in acute myeloid leukemia (AML).

GSK-LSD1 2HCl irreversibly inhibited LSD1 with IC50 value of 16 nM and is > 1000 fold selective over LSD2, MAO-A and MAO-B, which were related to FAD utilizing enzymes. In cancer cell lines, GSK-LSD1 2HCl changed gene expression with average EC50 value < 5 nM and inhibited cells growth with average EC50 value < 5 nM. GSK-LSD1 2HCl (10 ?M) inhibited human recombinant dopamine transporter, 5-HT1A and 5-HT transporter by 39%, 49% and 74%, respectively. And no activity against other 55 recombinant receptors (GPCR, transporters, ion channels). GSK-LSD1 2HCl can be used as a chemical probe and a part of the SGC epigenetics [1].

Reference:
[1].  Structural Genomics Consortium.
http://www. thesgc.org/chemical-probes/LSD1.

レビュー

Review for GSK-LSD1 2HCl

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GSK-LSD1 2HCl

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.